Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
News Briefing channel feed
Evofem inks women’s health deal; AusperBio brings in $37M
10 months ago
Ideaya raises $302M; AbbVie to seek approval in giant cell arteritis
10 months ago
Faron details clinical plans for MDS drug; Cara to seek 'strategic' options
10 months ago
Ideaya aims to raise $263M; Immuneel extends Series A with $12M
10 months ago
Kymera's stock rises after derma investigation expands; Ligand buys Apeiron
10 months ago
Vanqua raises $45M; Aerovate to look for strategic alternatives
10 months ago
Innovent reworks deal with IASO; Granza raises $7M
10 months ago
Yuhan, Ubix ink licensing deal; Xenpozyme's royalty deal
10 months ago
Tracon to seek ‘strategic’ options; Ovid to lay off 17 workers
10 months ago
Savara’s $100M offering; New biotech to test Eisai drug in Ph2
11 months ago
Recursion’s $200M offering; Sanofi invests $40M in Vigil Neuroscience
11 months ago
Taysha’s $75M offering; Augustine raises €17M
11 months ago
Zealand Pharma aims to raise $900M; Boehringer discontinues three Phase 2 trials
11 months ago
Corrected: Entrada raises $100M for Duchenne development; eFFECTOR winds down
11 months ago
Layoffs at Ginkgo and Xellia; Melodia and Alivexis ink $275M partnership
11 months ago
Forbion's new €75M fund; Cara Therapeutics to cut workforce after trial failure
11 months ago
A new obesity biotech; UroGen aims to raise $107M
11 months ago
Argenx drops post-Covid syndrome program; Mirum picks a dose for bile duct disease drug
11 months ago
Takeda signs option deal for TKI inhibitor; Enveda's $55M raise
11 months ago
Avidity’s $300M offering; Rapport raises $174M
11 months ago
Alzheon raises $100M; Regeneron ends mid-stage trial
11 months ago
ADC startup raises €30M; Cyrus Biotechnology to spin out Levitate Bio
11 months ago
Shionogi inks deal for preclinical hearing loss therapies; Alvotech’s refinancing pact
11 months ago
Replimune aims for accelerated approval of melanoma therapy; Structure's upsized $476M offering
11 months ago
First page
Previous page
6
7
8
9
10
11
12
Next page
Last page